TerrAscend (TSNDF) Raw Materials (2021 - 2026)

TerrAscend's (TSNDF) quarterly Raw Materials came in at $919000.0 in Q1 2026, down 4.17% year-on-year from $959000.0 in Q1 2025, and up 22.05% on a QoQ basis from $753000.0 in Q4 2025.

TerrAscend (TSNDF) Raw Materials (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Raw Materials data on file, last reported at $919000.0 in Q1 2026.

  • On a quarterly basis, Raw Materials fell 4.17% year-over-year to $919000.0 in Q1 2026; TTM through Mar 2026 was $919000.0, a 4.17% decrease from a year earlier, with the FY2025 full-year figure at $753000.0, up 88.25% from the prior year.
  • Raw Materials for Q1 2026 stood at $919000.0, up from $753000.0 in the prior quarter.
  • Over the last five years, Raw Materials for TSNDF reached as high as $7.2 million in Q2 2022 and fell as low as $378000.0 in Q4 2023.
  • Historically, Raw Materials has averaged $1.8 million across 5 years, with a median of $919000.0 in 2026.
  • Across the five-year window, Raw Materials surged 339.03% in 2022 and tumbled 80.37% in 2023, its largest moves.
  • Year by year, Raw Materials stood at $1.2 million in 2022, then tumbled by 67.99% to $378000.0 in 2023, then advanced by 5.82% to $400000.0 in 2024, then soared by 88.25% to $753000.0 in 2025, then climbed by 22.05% to $919000.0 in 2026.
  • Per Business Quant data, the three most recent Raw Materials figures were $919000.0 in Q1 2026, $753000.0 in Q4 2025, and $705000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 TerrAscend 160.44 Mn 162.98 Mn 34.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 919,000.00
Dec 31, 2025 753,000.00
Sep 30, 2025 705,000.00
Jun 30, 2025 520,000.00
Mar 31, 2025 959,000.00
Dec 31, 2024 400,000.00
Sep 30, 2024 459,000.00
Jun 30, 2024 552,000.00
Mar 31, 2024 730,000.00
Dec 31, 2023 378,000.00
Sep 30, 2023 1.69 Mn
Jun 30, 2023 1.41 Mn
Mar 31, 2023 1.66 Mn
Dec 31, 2022 1.18 Mn
Sep 30, 2022 6.83 Mn
Jun 30, 2022 7.16 Mn
Mar 31, 2022 4.34 Mn
Dec 31, 2021 269,000.00